Sep 14, 2022 / 04:15PM GMT
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
My name is Jeff Johnson. I'm the senior medical technology analyst at Baird, and our next presentation this afternoon is from Insulet Corporation, a leader in the $3 billion global insulin pump market. With us today from Insulet, we're happy to have Chief Executive Officer, Jim Hollingshead; Chief Financial Officer, Wayde McMillan; and Vice President of Investor Relations, Deb Gordon. Jim, I'm going to turn it over to you if you have a few minutes of any prepared remarks you'd like to make, and then we'll move right into Q&A.
James R. Hollingshead - Insulet Corporation - President, CEO & Director
Yes, great. Thanks, Jeff, and hello, everybody. Good afternoon. Thanks for being with us today. We're already on the clock here so we're at 27 minutes and counting, we can see up here, so I'll be brief. Insulet was founded over 20 years ago with a really clear mission, which is to simplify and improve the lives for people with diabetes.
And diabetes,
Insulet Corp at Robert W Baird Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers